Cetirizine Hydrochloride Market

Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.
The global average price of Cetirizine Hydrochloride is in the decreasing trend, from 52.7 USD/K Units in 2012 to 47.7 USD/K Units in 2017. With the situation of global economy and increasing generic medicine, prices will be in decreasing trend in the following five years.
The classification of Cetirizine Hydrochloride includes tablet, capsule and solution, and tablet type of Cetirizine Hydrochloride is the largest segment in the market, its proportion in 2016 is about 45%. Cetirizine Hydrochloride is widely consumed in hospitals, clinics and drug store. The most large application proportion of Cetirizine Hydrochloride is drug store.
Europe is the largest supplier of Cetirizine Hydrochloride, with a production market share over 50% in 2016. USA is the second largest supplier of Cetirizine Hydrochloride products, enjoying production market share nearly 28% in 2016.

The report offers detailed coverage of Cetirizine Hydrochloride industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Cetirizine Hydrochloride by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

The report forecast global Cetirizine Hydrochloride market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2027.

First, this report covers the present status and the future prospects of the global Cetirizine Hydrochloride market for 2015-2027.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
UCB Pharma
Pfizer
J & J
Mylan
Teva
HUAPONT Pharm
Hunan Jiudian Pharm
Sun Pharma
Lunan Pharma
Jubilant Life Sciences
Amneal
HAILISHENG

At the same time, we classify Cetirizine Hydrochloride according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market Segment as follows:
Market by Order Type
Tablet
Capsule
Solution
Market by Application
Hospital
Clinic
Drug Store

By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Cetirizine Hydrochloride market for the forecast period 2021 - 2027?
• What are the driving forces in the Cetirizine Hydrochloride market for the forecast period 2021 - 2027?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Cetirizine Hydrochloride industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?